Funding

Synakis Corp

Canada · Biotech · Healthtech

Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage

Visit synakis.caFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Pre-SeedCA$2.6MCanadian Glycomics Network — Role not disclosedChiefswood Private Capital Inc. — Role not disclosedOntario Centre of Innovation — Role not disclosedToronto Innovation Acceleration Partners — Role not disclosed

Investors

Canadian Glycomics NetworkPre-SeedChiefswood Private Capital Inc.Pre-SeedOntario Centre of InnovationPre-SeedToronto Innovation Acceleration PartnersPre-Seed

Coverage

May 21, 2026Synakis Corp · Pre-Seed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcessynakis.ca ↗